D-0799-2020 Class II Terminated

Recalled by Advanced Accelerator Applications USA, Inc. — Millburn, NJ

FDA drug recall D-0799-2020 was initiated by Advanced Accelerator Applications USA, Inc. on Jan 10, 2020 and is designated Class II. Reason for recall: Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2). The recall status is terminated (terminated Jul 21, 2023). Affected quantity: 4295 Kits.

Recall details

Product Type
Drugs
Report Date
Jan 29, 2020
Initiation Date
Jan 10, 2020
Termination Date
Jul 21, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4295 Kits

Product description

NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

Reason for recall

Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).

Distribution pattern

Nationwide in the US and Canada

Code information

Lot #: PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0799-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0799-2020. Report a data issue: hello@regdatalab.com.